US Broker Ratings

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A Biotech Powerhouse with 20% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the healthcare sector, specifically within the biotechnology industry, has captured the attention of investors with its impressive 20.71% potential upside. Based..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 22.59% Upside Potential in the Biotech Sector

TG Therapeutics, Inc. (NASDAQ: TGTX) is capturing the attention of investors with its promising 22.59% potential upside, according to the latest analyst ratings. As a key player in the healthcare..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Healthcare Under the Spotlight with a 4.15% Upside

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry, is drawing investors’ attention with its unique positioning in the managed healthcare sector. With its primary focus..

Qiagen N.V. (QGEN) Stock Report: A Healthcare Giant with a Potential Upside of 6.78%

Qiagen N.V. (QGEN), a prominent player in the healthcare sector, continues to be a focal point for investors in the diagnostics and research industry. Headquartered in Venlo, Netherlands, Qiagen specializes..

AstraZeneca PLC (AZN) Stock Analysis: Is a 27.75% Upside on the Horizon?

AstraZeneca PLC (NASDAQ: AZN), a leading biopharmaceutical company headquartered in Cambridge, UK, continues to capture investor attention with its robust pipeline of prescription medicines and strategic partnerships. With a market..

Bruker Corporation (BRKR) Stock Analysis: Assessing Growth Potential Amid a Rapidly Evolving Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $9.35 billion, this Massachusetts-based company has..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring Growth Potential with a 13.71% Upside

Investors seeking opportunities in the medical instruments and supplies sector might find Stevanato Group S.p.A. (NYSE: STVN) an intriguing prospect. With a market capitalization of $5.92 billion, Stevanato Group has..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: 18.84% Potential Upside Beckons Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $5.1 billion, Merit Medical..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Promising 31.56% Upside in the Precision Oncology Space

Revolution Medicines, Inc. (NASDAQ: RVMD) commands attention within the biotechnology sector, boasting a remarkable market capitalization of $40.93 billion. This clinical-stage precision oncology company, headquartered in Redwood City, California, is..

Repligen Corporation (RGEN) Investor Outlook: Strong Buy Ratings and Growth Potential in Bioprocessing Technologies

Repligen Corporation (NASDAQ: RGEN) stands out in the healthcare sector, particularly within the medical instruments and supplies industry, as a dynamic player with significant growth potential. With a market capitalization..

BeOne Medicines Ltd. (ONC) Stock Analysis: A 23% Potential Upside in the Biotech Sector

BeOne Medicines Ltd. (ONC), a Swiss-based oncology-focused biotechnology company, has caught the attention of investors with its promising pipeline of cancer treatments and a significant potential upside reflected in recent..

Genmab A/S (GMAB) Stock Analysis: Strong Buy Ratings and 12.66% Potential Upside Drive Investor Interest

Genmab A/S (NASDAQ: GMAB), a powerhouse in the biotechnology sector, has piqued the interest of investors with its robust performance and potential for growth. Headquartered in Copenhagen, Denmark, Genmab specializes..

Glaukos Corporation (GKOS) Stock Analysis: Investors Eye 20% Upside Potential Amid Robust Revenue Growth

Glaukos Corporation (NYSE: GKOS), a leading player in the healthcare sector specializing in medical devices, has captured the attention of investors with its promising growth prospects and innovative product pipeline...

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Biotech Leader with a 55% Upside Potential

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands at the forefront of the biotechnology sector, with a market cap of $32.06 billion, making it a significant player in the development of RNA..

ICON plc (ICLR)

⚠️ No article content returned.

..

Royalty Pharma plc (RPRX) Stock Analysis: Exploring a 11.5% Potential Upside in the Biotech Royalty Space

Royalty Pharma plc (NASDAQ: RPRX) is a prominent player in the healthcare sector, particularly within the biotechnology industry, where it stands out as a unique entity. Operating out of New..

McKesson Corporation (MCK)

⚠️ No article content returned.

..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Navigating a 28.64% Potential Upside

In the ever-evolving landscape of the healthcare sector, GE HealthCare Technologies Inc. (NYSE: GEHC) stands as a formidable player within the medical devices industry. With a market capitalization of $29.17..

Henry Schein, Inc. (HSIC) Stock Analysis: A Promising 15.73% Upside in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a leader in the healthcare sector, stands as a formidable player in the medical distribution industry. With a market capitalization of $9.66 billion, Henry Schein..

Grifols, S.A. (GRFS)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds